WFPHA Webinar: "Why Do We Need Personalised Medicine in Cancer? The Case of The EU and China"

Desde el miércoles, 23 de marzo de 2022 hasta el miércoles, 23 de marzo de 2022

FREE LIVE WEBINAR

23 March 2022 | 10:00 – 11:30 (CET)

Participation is FREE. Save Your Spot: https://www.eventbrite.co.uk/e/why-do-we-need-personalised-medicine-in-cancer-the-case-of-the-eu-china-tickets-272123437527

Cancer is a devastating disease that kills hundreds of thousands of people every year. The rapidly evolving field of personalised medicine is playing an increasingly important role in the prevention, diagnosis and treatment of cancer. Much investment is being made in research related to personalised medicine to improve health outcomes for patients.

Integrating China in the International Consortium for Personalized Medicine (IC2PerMed) project is a Horizon 2020 Coordination and Support Action which aims to provide policy makers with key solutions to enable the convergence of a common approach to personalised medicine. IC2PerMed aims to support collaboration between the EU and China on personalised medicine research, innovation and policy developments.

During the webinar, thought leaders from Italy and China will discuss why we need personalised medicine for cancer and provide examples and recommendations for effective implementation of this approach in different settings.

Chair:

Prof. Walter Ricciardi, President, The World Federation of Public Health Associations.

Speakers:

Prof. Stefania Boccia, Full Professor of Hygiene and Preventive Medicine, Università Cattolica del Sacro Cuore.
Dr. Shuhang Wang, Clinical Director, GCP Center, Cancer Hospital Chinese Academy of Medical Science.

Keep up to date with all the activities and news relating to the event by following us on our social media.

Twitter: https://twitter.com/WFPHA_FMASP

Facebook: https://www.facebook.com/ngowfpha/

LinkedIn: https://www.linkedin.com/company/wfpha

YouTube: https://www.youtube.com/channel/UCm2sHZZxpVNaX8GiiI07V6w?view_as=subscriber

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874694

If you have any questions, don't hesitate to contact us.

Stay Safe; Stay Healthy!